Analysis of the Costs Associated With the Elective Evaluation of Patients Labelled as Allergic to Beta-Lactams or Nonsteroidal Antiinflamatory Agents

Analysis of the Costs Associated With the Elective Evaluation of Patients Labelled as Allergic to Beta-Lactams or Nonsteroidal Antiinflamatory Agents

Introduction: Being labelled as allergic to different drugs results in patients receiving other treatments, which are more toxic, less effective and more expensive. We aimed to analyze different studies of the costs of drug hypersensitivity assessment.Methods: A bibliographic search on studies regar...

Full description

Bibliographic Details
Main Authors: Miriam Sobrino-García, Esther M. Moreno, Francisco J. Muñoz-Bellido, Maria T. Gracia-Bara, Elena Laffond, Inmaculada Doña, Cristina Martín, Eva M. Macías, Sonia de Arriba, Valle Campanón, Alicia Gallardo, Ignacio Dávila
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
beta-lactam
cost
delabelling
drug hypersensitivity
non-steroidal anti-inflammatory drug
penicillin
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.584633/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.584633/full

Similar Items